Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis

The coronavirus disease 2019 (COVID-19) pandemic has become a global health crisis. Considering the recent food and drug administration (FDA) approval of remdesivir as the first officially approved agent for COVID-19 treatment, we performed this systematic review and meta-analysis to evaluate the ef...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of pharmacology 2021-04, Vol.897, p.173926-173926, Article 173926
Hauptverfasser:	Rezagholizadeh, Afra, Khiali, Sajad, Sarbakhsh, Parvin, Entezari-Maleki, Taher
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenosine Monophosphate - adverse effects Adenosine Monophosphate - analogs & derivatives Adenosine Monophosphate - therapeutic use Alanine - adverse effects Alanine - analogs & derivatives Alanine - therapeutic use Antiviral Agents - adverse effects Antiviral Agents - therapeutic use Coronavirus COVID-19 COVID-19 Drug Treatment Humans Meta-analysis Pandemics Randomized Controlled Trials as Topic Remdesivir Review SARS-CoV-2 Systematic review Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!